Lataa...
Amyloid Beta (A4) Precursor Protein: A Potential Biomarker for Recurrent Nasopharyngeal Carcinoma
BACKGROUND AND AIM: Nasopharyngeal carcinoma (NPC) is one of the most common cancers in Southern China, Southeast Asia. Radiotherapy is the main treatment for NPC. Still, about 20% of patients with NPC have a recurrence. No effective serum biomarkers are available for recurrent nasopharyngeal carcin...
Tallennettuna:
| Julkaisussa: | Cancer Manag Res |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6929967/ https://ncbi.nlm.nih.gov/pubmed/31908537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S218030 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|